Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of a 200-mcg Dose of CEP-33457 in Patients With Systemic Lupus Erythematosus

NCT01135459 is registered in ClinicalTrials.gov with Cephalon, Inc. as lead sponsor.

NCT NCT01135459
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01135459 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of a 200-mcg Dose of CEP-33457 in Patients With Systemic Lupus Erythematosus
Lead sponsor
Cephalon, Inc.
Phase
Phase 2
Overall status
Completed
Start date
June 24, 2010
Completion date
June 30, 2012
Enrollment
183 (actual)
Sites
86

Conditions

As the registry lists them; a condition with its own page is linked.

systemic lupus erythematosus